Triplets versus doublets with or without cisplatin in the first-line treatment of stage IIIB-IV nonsmall cell lung cancer (NSCLC) patients: Preliminary results of a multicenter randomized factorial study

MLA

Tiseo, M., et al. Triplets versus Doublets with or without Cisplatin in the First-Line Treatment of Stage IIIB-IV Nonsmall Cell Lung Cancer (NSCLC) Patients: Preliminary Results of a Multicenter Randomized Factorial Study. Jan. 2007. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..4ad38e58b0ed8212451708c67f214182&authtype=sso&custid=ns315887.

APA

Tiseo, M., Boni, C., Baldini, E., Luca Boni, Recchia, F., Barone, C., Manzione, L., Grossi, F., Matano, E., Zanelli, F., Prochilo, T., & Ardizzoni, A. (2007). Triplets versus doublets with or without cisplatin in the first-line treatment of stage IIIB-IV nonsmall cell lung cancer (NSCLC) patients: Preliminary results of a multicenter randomized factorial study.

Chicago

Tiseo, M., C. Boni, E. Baldini, Luca Boni, F. Recchia, C. Barone, L. Manzione, et al. 2007. “Triplets versus Doublets with or without Cisplatin in the First-Line Treatment of Stage IIIB-IV Nonsmall Cell Lung Cancer (NSCLC) Patients: Preliminary Results of a Multicenter Randomized Factorial Study,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..4ad38e58b0ed8212451708c67f214182&authtype=sso&custid=ns315887.